trending Market Intelligence /marketintelligence/en/news-insights/trending/IijW7la8wqgFjinafY5FWg2 content esgSubNav
In This List

NewLink Genetics prices common stock offering

Blog

Insight Weekly: Energy crisis cripples Europe; i-bank incomes rise; US holiday sales outlook

Blog

Japan M&A By the Numbers: Q3 2022

Blog

Insight Weekly: Reviving nuclear power; 2023 outlook for US financials; PE funds fuel EV sector

Blog

Insight Weekly: Energy reforms after midterms; Crisis ends 'age of gas'; bank deposits fall


NewLink Genetics prices common stock offering

NewLink Genetics Corp. priced an underwritten public offering of 5 million common shares at $10.25 apiece.

The company granted underwriters a 30-day option to buy up to an additional 750,000 common shares on the same terms and conditions.

The offering is expected to close by Oct. 6, subject to customary closing conditions.

NewLink Genetics plans to use net proceeds to fund research and development for its product candidates, in addition to working capital and general corporate purposes.

BofA Merrill Lynch and Stifel are acting as joint book-running managers for the offering, with Baird as co-manager.